## **Core Concept**
The question pertains to the mechanisms that enhance cancer cell survival. Cancer cells often develop strategies to evade apoptosis (programmed cell death) and sustain their growth and survival. One key pathway involved in cell survival is the PI3K/AKT signaling pathway.

## **Why the Correct Answer is Right**
The correct answer, **B. Inhibition of PTEN**, enhances cancer cell survival by promoting the PI3K/AKT pathway. PTEN (Phosphatase and Tensin Homolog) is a tumor suppressor gene that negatively regulates the PI3K/AKT pathway by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PIP3), the product of PI3K activity. When PTEN is inhibited or mutated, PIP3 levels increase, leading to the activation of AKT. Activated AKT promotes cell survival by inhibiting pro-apoptotic proteins and enhancing anti-apoptotic proteins, thus supporting cancer cell survival and proliferation.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that PTEN loss or mutation is commonly seen in various cancers, including prostate, breast, and endometrial cancers. This loss can be used as a biomarker for predicting the efficacy of certain targeted therapies. For example, cancers with PTEN loss may be more resistant to certain treatments, making PTEN status an important consideration in cancer therapy planning.

## **Correct Answer:** . Inhibition of PTEN